News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
635,068 Results
Type
Article (57789)
Company Profile (215)
Press Release (577053)
Multimedia
Podcasts (149)
Webinars (22)
Section
Business (165444)
Career Advice (2478)
Deals (30477)
Drug Delivery (146)
Drug Development (78822)
Employer Resources (160)
FDA (16641)
Job Trends (13650)
News (299313)
Policy (32196)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2617)
Academic (1)
Accelerated approval (40)
Adcomms (36)
Allergies (153)
Alliances (42542)
ALS (175)
Alzheimer's disease (1752)
Antibody-drug conjugate (ADC) (364)
Approvals (16824)
Artificial intelligence (552)
Autoimmune disease (177)
Automation (38)
Bankruptcy (324)
Best Places to Work (10601)
BIOSECURE Act (23)
Biosimilars (204)
Biotechnology (151)
Bladder cancer (172)
Brain cancer (66)
Breast cancer (693)
Cancer (5279)
Cardiovascular disease (431)
Career advice (2102)
Career pathing (40)
CAR-T (305)
CDC (67)
Celiac Disease (1)
Cell therapy (805)
Cervical cancer (39)
Clinical research (67139)
Collaboration (1712)
Company closure (4)
Compensation (1199)
Complete response letters (78)
COVID-19 (2809)
CRISPR (97)
C-suite (871)
Cystic fibrosis (145)
Data (6338)
Decentralized trials (2)
Denatured (35)
Depression (151)
Diabetes (505)
Diagnostics (6428)
Digital health (41)
Diversity (8)
Diversity, equity & inclusion (43)
Drug discovery (257)
Drug pricing (224)
Drug shortages (33)
Duchenne muscular dystrophy (255)
Earnings (68514)
Editorial (69)
Employer branding (20)
Employer resources (144)
Events (97023)
Executive appointments (954)
FDA (19870)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (22)
Funding (1444)
Gene editing (209)
Generative AI (45)
Gene therapy (655)
GLP-1 (1094)
Government (4657)
Grass and pollen (8)
Guidances (383)
Healthcare (17273)
HIV (73)
Huntington's disease (52)
IgA nephropathy (89)
Immunology and inflammation (298)
Immuno-oncology (75)
Indications (126)
Infectious disease (3101)
Inflammatory bowel disease (203)
Inflation Reduction Act (14)
Influenza (120)
Intellectual property (252)
Interviews (462)
IPO (15122)
IRA (58)
Job creations (3388)
Job search strategy (1717)
JPM (70)
Kidney cancer (19)
Labor market (85)
Layoffs (635)
Leadership (43)
Legal (7559)
Liver cancer (100)
Longevity (16)
Lung cancer (714)
Lymphoma (392)
Machine learning (44)
Management (54)
Manufacturing (808)
MASH (177)
Medical device (12285)
Medtech (12335)
Mergers & acquisitions (16403)
Metabolic disorders (1378)
mRNA (191)
Multiple sclerosis (157)
NASH (22)
Neurodegenerative disease (345)
Neuropsychiatric disorders (102)
Neuroscience (3037)
Neurotech (1)
NextGen: Class of 2026 (5675)
Non-profit (4110)
Now hiring (40)
Obesity (684)
Opinion (301)
Ovarian cancer (173)
Pain (203)
Pancreatic cancer (250)
Parkinson's disease (293)
Partnered (29)
Patents (516)
Patient recruitment (528)
Peanut (61)
People (50488)
Pharmaceutical (46)
Pharmacy benefit managers (33)
Phase 1 (20873)
Phase 2 (29179)
Phase 3 (22666)
Pipeline (5657)
Policy (349)
Postmarket research (2622)
Preclinical (8838)
Press Release (37)
Prostate cancer (270)
Psychedelics (57)
Radiopharmaceuticals (309)
Rare diseases (958)
Real estate (4927)
Recruiting (65)
Regulatory (24764)
Reports (43)
Research institute (2435)
Resumes & cover letters (410)
Rett syndrome (30)
RNA editing (20)
RSV (84)
Schizophrenia (160)
Series A (236)
Series B (188)
Service/supplier (9)
Sickle cell disease (105)
Special edition (27)
Spinal muscular atrophy (164)
Sponsored (47)
Startups (3132)
State (1)
Stomach cancer (21)
Supply chain (111)
Tariffs (101)
The Weekly (113)
Vaccines (1147)
Venture capital (100)
Weight loss (479)
Women's health (90)
Worklife (23)
Date
Today (39)
Last 7 days (855)
Last 30 days (2756)
Last 365 days (29704)
2026 (4797)
2025 (30087)
2024 (33769)
2023 (37948)
2022 (48573)
2021 (52304)
2020 (49620)
2019 (41269)
2018 (31195)
2017 (30731)
2016 (29412)
2015 (32878)
2014 (26168)
2013 (21822)
2012 (23245)
2011 (23518)
2010 (22038)
Location
Africa (790)
Alabama (77)
Alaska (6)
Arizona (263)
Arkansas (13)
Asia (37624)
Australia (6792)
California (11210)
Canada (2892)
China (1089)
Colorado (437)
Connecticut (500)
Delaware (322)
Europe (90369)
Florida (1686)
Georgia (339)
Hawaii (4)
Idaho (51)
Illinois (830)
India (64)
Indiana (506)
Iowa (23)
Japan (432)
Kansas (118)
Kentucky (39)
Louisiana (20)
Maine (78)
Maryland (1394)
Massachusetts (8143)
Michigan (285)
Minnesota (599)
Mississippi (5)
Missouri (122)
Montana (21)
Nebraska (24)
Nevada (117)
New Hampshire (67)
New Jersey (3006)
New Mexico (21)
New York (2969)
North Carolina (1465)
North Dakota (7)
Northern California (5570)
Ohio (325)
Oklahoma (16)
Oregon (37)
Pennsylvania (2191)
Puerto Rico (19)
Rhode Island (36)
South America (1133)
South Carolina (66)
South Dakota (1)
Southern California (4345)
Tennessee (167)
Texas (1835)
United States (39662)
Utah (298)
Virginia (260)
Washington D.C. (77)
Washington State (908)
West Virginia (4)
Wisconsin (121)
Wyoming (1)
635,068 Results for "texas children s cancer centre".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Manufacturing
Novartis Names Texas City as Location of Its 5th US Radiopharmaceutical Facility
The Denton site is part of a network of manufacturing plants Novartis is building across the U.S. to make cancer drugs that must be shipped to patients quickly.
February 25, 2026
·
2 min read
·
Nick Paul Taylor
Stomach cancer
Jazz’s Ziihera Shows ‘Practice-Changing’ Efficacy in Stomach Cancer
Jazz’s Ziihera and BeOne’s Tevimbra plus chemotherapy led to what Truist Securities dubbed one of the strongest overall survival signals ever reported in a type of gastroesophageal cancer.
January 7, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Jonathan D. Santoro, MD, Appointed Chief of Neurology and Co-Director of the Neurological Institute at Children’s Hospital Los Angeles
February 12, 2026
·
3 min read
Collaboration
Astellas Bets up to $1.7B for Vir’s ‘Robust Competitor’ in Prostate Cancer
In a Phase 1 study, 82% of patients on VIR-5500 achieved at least a 50% reduction in PSA levels—a result analysts praised as competitive in the prostate cancer space.
February 24, 2026
·
2 min read
·
Tristan Manalac
Press Releases
The Oxford-Harrington Rare Disease Centre Advances Discovery of Therapies for Friedreich’s Ataxia (FA)
February 9, 2026
·
7 min read
Press Releases
St. Jude Children’s Research Hospital and ALSAC Announce New Board Members
November 20, 2025
·
6 min read
Press Releases
LifeLabs Care Packages Bring Comfort to Children with Cancer at POGO Satellite Clinics
October 28, 2025
·
3 min read
Press Releases
Texas Children’s Provides New Breakthrough Treatment for Patient with Rare Neurological Disorder
August 20, 2025
·
4 min read
Press Releases
Press Release: Sanofi and Regeneron’s Dupixent recommended for EU approval to treat chronic spontaneous urticaria in young children with ongoing symptoms despite treatment
February 27, 2026
·
14 min read
Startups
Harbour Cofunds Cancer Startup, Hands Off Clinical-Stage Antibody
Solstice Oncology will gain an exclusive worldwide license to Harbour BioMed’s porustobrt, an anti-CTLA-4 antibody currently being studied for melanoma, colorectal cancer and other malignancies in China.
February 25, 2026
·
2 min read
·
Tristan Manalac
1 of 63,507
Next
